Immunologic aspects of multiple sclerosis
Taylor, R.S.
Physical Medicine and Rehabilitation Clinics of North America 9(3): 525
1998
ISSN/ISBN: 1047-9651 PMID: 9894106 Document Number: 490868
Multiple sclerosis (MS) is the most common autoimmune disease involving the central nervous system. Knowledge of the basic autoimmunologic properties related to MS is critical to formulating a logical treatment approach to the patient. A review of immunologic systems and their specific applicability to MS is included in this article.
Document emailed within 1 workday
Related Documents
Maciejek, Z. 1990: Multiple sclerosis--biochemical-immunologic and therapeutic aspects Wiadomosci Lekarskie 43(5-6): 232-239Mal'tsev, D.V. 2014: Unresolved problems and the prospects for research in area of the multiple sclerosis: virologic, immunologic and therapeutic aspects Likars'ka Sprava 2014(5-6): 3-19
Prokof'ev, V.F.; Konenkov, V.I.; Gribacheva, I.A.; Voronova, I.A.; Doronin, B.M. 1989: Clinico-immunologic parallels in multiple sclerosis Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 89(2): 31-34
Mavra, M.; Vranjesević, D.; Radosavljević, B. 1984: Immunologic profile of cerebrospinal fluid in multiple sclerosis in childhood Srpski Arhiv Za Celokupno Lekarstvo 112(2): 205-214
Hauser, S.L.; Fosburg, M.; Kevy, S.V.; Weiner, H.L. 1984: Lymphocytapheresis in chronic progressive multiple sclerosis: immunologic and clinical effects Neurology 34(7): 922-926
Cazzullo, C.L.; Montanini, R.; Ghezzi, A.; Zaffaroni, M.; Giussani, D.; Loner, R.; Caputo, D.; Marforio, S.; Zibetti, A. 1984: Clinical, immunologic and electrophysiologic correlations in evaluating multiple sclerosis in relation to its development Minerva Medica 75(43): 2585-2589
Kastrukoff, L.F.; Oger, J.J.; Tourtellotte, W.W.; Sacks, S.L.; Berkowitz, J.; Paty, D.W. 1991: Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. II. Immunologic evaluation Neurology 41(12): 1936-1941
Gonsette, R.E. 1982: Therapeutic aspects of multiple sclerosis Bulletin de la Societe Belge d'Ophtalmologie 199-200: 275-280
Taylor, A.; Taylor, R.S. 1998: Neuropsychologic aspects of multiple sclerosis Physical Medicine and Rehabilitation Clinics of North America 9(3): 643
Abramsky, O.; Lisak, R.P. 1978: Immunobiological aspects of multiple sclerosis Harefuah 94(9): 283-286
Matcău, L.; Sofletea, A.; Minciu, E.; Marcovici, H.; Creţu, M. 1968: Clinical aspects of multiple sclerosis Neurologia Psihiatria Neurochirurgia 13(6): 493-502
Grimaud, J.; Pageot, N.; Rovaris, M. 2001: Parallels between clinical aspects and MRI in multiple sclerosis Revue Neurologique (Paris) 157(8-9 Part 1): 884-890
Schanke, A.K.; Grimsmo, J.; Sundet, K. 1995: Multiple sclerosis and prerequisites for driver's licence. A retrospective study of 33 patients with multiple sclerosis assessed at Sunnaas hospital Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 115(11): 1349-1352
Bykova, O.V.; Nankina, I.A.; Platonova, A.N.; Karpacheva, N.G.; Petrova, O.A.; Gorina, T.P.; Batysheva, T.T.; Serkov, S.V.; Kuzenkova, L.M. 2013: Differential diagnosis of multiple sclerosis with pediatric onset: the experience of the Moscow Division for treatment of children and adolescents with multiple sclerosis Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 113(10 Pt 2): 61-68
Laosanguanek, N.; Wiroteurairuang, T.; Siritho, S.; Prayoonwiwat, N. 2011: Reliability of the Thai version of SF-36 questionnaire for an evaluation of quality of life in multiple sclerosis patients in multiple sclerosis clinic at Siriraj Hospital Journal of the Medical Association of Thailand 94 Suppl. 1: S84-S88
Maschke, M.; Limmroth, V. 2003: Multiple sclerosis. Current aspects of the disease and treatment Medizinische Monatsschrift für Pharmazeuten 26(12): 404-408; Quiz: 409-410
Łobińska, A.; Stelmasiak, Z. 2004: Epidemiological aspects of multiple sclerosis in Lublin (Poland) Neurologia i Neurochirurgia Polska 38(5): 361-366
Parkhomenko, V.M.; Nosenko, S.P. 1978: Some aspects of the peripheral circulation in patients with multiple sclerosis Human Physiology 4(1): 61-64
Reclos, G.J.; Baxevanis, C.N.; Sfagos, C.; Papageorgiou, C.; Tsokos, G.C.; Papamichail, M. 1987: Multiple sclerosis: II. Effects of prothymosin alpha on the autologous and allogeneic MLR in patients with multiple sclerosis Clinical and Experimental Immunology 70(2): 336-344
Spirin, N.N.; Baranova, N.S.; Fadeeva, O.A.; Shipova, E.G.; Stepanov, I.O. 2011: Differential aspects of multiple sclerosis and chronic borrelial encephalomyelitis Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 111(7): 8-12